EX-VIVO AND IN-VIVO OPTICAL MOLECULAR PATHOLOGY

類似書籍推薦給您

【簡介】 The result of a unique collaboration between clinicians, chemists and physicists, this book provides an unparalleled overview of a new generation of diagnostic tools in clinical pathology. The introductory chapters cover the present status and limitations of currently used methods, followed by an outline of promising novel spectroscopy-based technologies either under development or recently available on the market. The input from both technologists developing these new methods as well as routine clinicians familiar with practical aspects and medical relevance guarantees that this practical work is a valuable asset for a wide audience, including technical personnel and decision makers in treatment centers, experts working in companies developing diagnostic devices, and clinicians specializing in advanced diagnostic methods. Since basic researchers are increasingly adopting novel diagnostic tools developed for human use as well, this will also be of interest for biomedical research institutions with large animal facilities. 【目錄】

IN VIVO MODELS FOR DRUG DISCOVERY

類似書籍推薦給您

【簡介】 This one-stop reference is the first to present the complete picture -- covering all relevant organisms, from single cells to mammals, as well as all major disease areas, including neurological disorders, cancer and infectious diseases. Addressing the needs of the pharmaceutical industry, this unique handbook adopts a broad perspective on the use of animals in the early part of the drug development process, including regulatory rules and limitations, as well as numerous examples from real-life drug development projects. After a general introduction to the topic, the expert contributors from research-driven pharmaceutical companies discuss the basic considerations of using animal models, including ethical issues. The main part of the book systematically surveys the most important disease areas for current drug development, from cardiovascular to endocrine disorders, and from infectious to neurological diseases. For each area, the availability of animal models for target validation, hit finding and lead profiling is reviewed, backed by numerous examples of both successes and failures among the use of animal models. The whole is rounded off with a discussion of perspectives and challenges. Key knowledge for drug researchers in industry as well as academia. 【目錄】